Lipid management refers to the management of cholesterol and triglyceride levels in the blood, which are risk factors for cardiovascular disease (CVD). Total cholesterol is a key factor for CVD events however, non-HDLC is the primary target for lipid lowering therapy (NICE-23).
CVD risk can be modified through appropriate management of the blood lipid profile, through promoting healthy lifestyle and/or cholesterol-lowering medications. Lipid management is one of the five NHS clinical priorities requiring accelerated improvement to reducing healthcare inequalities (NHS-E).
At Imperial College Health Partners we have been working closely with the North West London ICB to:
Explore our lipid management resources
You need to load content from reCAPTCHA to submit the form. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from Turnstile. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from Facebook. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from Instagram. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from Google Maps. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from X. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More Information